36C25921Q0013 0002.docx

5. PROJECT NUMBER (if applicable)

CODE

7. ADMINISTERED BY

2. AMENDMENT/MODIFICATION NUMBER

CODE

6. ISSUED BY

8. NAME AND ADDRESS OF CONTRACTOR

4. REQUISITION/PURCHASE REQ. NUMBER

3. EFFECTIVE DATE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED

PAGE OF PAGES

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED

BPA NO.

1. CONTRACT ID CODE

FACILITY CODE

CODE

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

E. IMPORTANT:

is extended,

(a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY is not extended.

12. ACCOUNTING AND APPROPRIATION DATA

(REV. 11/2016)

is required to sign this document and return ___________ copies to the issuing office.

is not, A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

15C. DATE SIGNED

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER

Contractor

16C. DATE SIGNED

14. DESCRIPTION OF AMENDMENT/MODIFICATION

16B. UNITED STATES OF AMERICA

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER

16A. NAME AND TITLE OF CONTRACTING OFFICER

15B. CONTRACTOR/OFFEROR

STANDARD FORM 30

PREVIOUS EDITION NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.243 (Type or print) (Type or print) (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

(Number, street, county, State and ZIP Code) (If other than Item 6) (Specify type of modification and authority) (such as changes in paying office, appropriation date, etc.)

(If required)

(SEE ITEM 11)

(SEE ITEM 13)

(X)

CHECK

ONE

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

(Signature of person authorized to sign) (Signature of Contracting Officer) 11-13-2020 na 36C259 Department of Veterans Affairs Network Contracting Office

NCO 19

6162 South Willow Drive, Suite 300 Greenwood Village CO 80111 36C259 Department of Veterans Affairs Network Contracting Office

NCO 19

6162 South Willow Drive, Suite 300 Greenwood Village CO 80111 To all Offerors/Bidders

36C25921Q0013 11-13-2020

X

X The purpose of this amendment is to answer the questions that were received. The statement of work and schedule of tests has been revised in response to the questions. Revised statement of work and revised schedule is attached.

Ronnie Jones Contracting Officer Questions and Answers for Solicitation# 36C25921Q0013 – Chemistry and Immunochemistry for RMR

1. A1c testing is currently contracted through Sept 2021 with Bio-Rad. Will A1c testing still be a part of this solicitation?

A. Yes, A1C testing will be part of this solicitation.

2. If the answer to the first questions is yes (A1c will be included in this solicitation), Can a bid be submitted for A1c only?

A. A bid or quote should be submitted for all tests required.

3. Section B.2, 3.c.(SOW) includes a statement regarding how third-party reagents (and products) are to be included. Please confirm this is for the current test menu and does not include the "additional tests" in the second bullet of B.2, 4. 4).

A. Yes, this for the current test menu.

4. Section B.2, 4. 4. (SOW) references a "current test menu is attached", however, no additional document was included in the event documents. Please confirm the "Description of Supplies (ASSAYS) in B.3. Schedule constitutes the referenced menu.

A. Yes, the Descriptions of test needed are in the B.3 Schedule and constitutes the referenced menu.

5. Section B.2, 4. 5 (SOW) last bullet. We understand this to mean vendors are not expected to include third party (e.g., BioRad) controls in their pricing and will not be part of this contract. Please confirm our interpretation is correct.

A. Yes, that is correct.

6. Section E.1 52.212-1, addendum, (5) states offerors shall respond to the technical evaluation factors, and this is not to exceed 5 double-sided pages, Times New Roman 12 pt font. Please confirm that "5, double-sided pages" equates to 10 single-sided pages when document is not being printed. Also, please confirm this technical evaluation factor (we presume this is Factor 1: Technical Data of E.11 52.212-2) document is in addition to the vendors responses to the paragraphs and sections within the SOW.

A. Yes, Technical proposal shall not exceed 5 double-sided pages or 10 single-sided pages. Yes, Factor 1: Technical Data needs to be addressed as well.

7. Can Troponin assay time be changed to < 20 minutes?

A. Yes, Troponin time is now changed to < 20 minutes.

8. Can time be removed from Intra-operative PTH?

A. Yes, time has been removed.

9. Can Live NT-Pro-BNP be or equivalent?

A. Yes, it may be equivalent to.

10. In Schedule of Test, can NT-BNP and Troponin 5th Gen be equivalents?

A. Yes, they can be equivalents.

11. Does sample aliquotter need to be on the line itself?

A. Yes, aliquotter needs to be on the automation line.

12. Does the refrigerated tube storage capacity need to be approximately 14,000 samples at one time?

A. Yes, the storage capacity needs to be approximately 14,000 samples at one time due to current workload and anticipated growth.

13. Can early detection and trouble shooting at the start of the automation line be changed?

A. Yes, it has now been changed.

14. Can section 4.1 in SOW be changed to remove integrated.

A. Yes, it has been removed.

B.2 STATEMENT OF WORK Chemistry and Immunochemistry Cost Per Reportable Result (CPRR)

1. SCOPE:

Contractor shall provide all equipment, reagents, standards, controls for troubleshooting purposes only, supplies, consumable/disposable items, parts, accessories and any other item required for the proper operation of its contractor owned chemistry analyzers and peripherals necessary for the generation of chemistry and Immunochemistry Cost Per Reportable Result (CPRR) services for the Rocky Mountain VA Medical Center (RMRVAMC) located at 1700 North Wheeling St, Aurora, CO, 80045.

2. DEFINITIONS:

Cost Per Reportable Result (CPRR): The per reportable result price shall include costs covering (a) equipment use, (b) all reagents, standards, supplies, consumable/disposable items, printers, parts, accessories and any other item required for the proper operation of the contractor’s equipment and necessary for the generation of a patient reportable result. This does not include those items approved for exclusion by the government such as printer paper, labels etc. This per patient reportable result price shall also encompass all costs associated with dilution, repeat and confirmatory testing required to produce a single patient reportable result. It will also include the material to perform as well as all other costs associated with calibration and correlation study testing that is prescribed by Clinical and Laboratory Standards Institute (CLSI). All necessary maintenance to keep the equipment in good operating condition (This element includes both preventive maintenance and emergency repairs and training for Government personnel. Contractors are required to provide delivery, installation and removal of equipment at no additional charge.

3. GENERAL REQUIREMENTS:

a. Offered models of clinical laboratory chemistry and immunochemistry analyzers shall be capable of producing accurate and reproducible assays on biological and other specimens by established in vitro diagnostic methods (see Proposed Rule by CMS 2/4/19 CLIA Proficiency Testing Regulations Related to Analytes and Acceptable Performance). Instrument models shall provide accurate test assay result for sample specimens up to the manufacturer's defined maximum test per hour without excessive malfunctions, breakdowns, or service calls.

· Offered testing equipment shall be new state-of-the-art equipment. Remanufactured and discontinued models will not be accepted.

· The contractor shall provide all upgrades to the equipment hardware and operating system software, at no additional cost to the Government during the lifetime of the instrument. These enhancements shall be delivered and installed at RMRVAMC within 60 days of issuance to the commercial market.

· The models being offered are in current production as of the date this offer is submitted. Current production shall mean that the clinical laboratory analyzer model is being manufactured as new equipment. Discontinued models that are only being made available as remanufactured equipment are not acceptable.

· Contractor offered equipment shall perform satisfactorily at any laboratory temperature between 64- and 90-degrees Fahrenheit (18 and 32 Celsius) and relative humidity and altitude at the site of use.

· An operator’s manual shall be furnished with each instrument supplied to RMRVAMC.

· Contractors offered chemistry analyzers and related equipment shall conform to RMRVAMC existing laboratory space.

b. Clinical laboratory assays currently performed at the RMRVAMC Pathology and Laboratory Medicine Services shall include but may not be limited to the following assays.

c. Pricing: Contractors shall provide pricing for each test in accordance with the CPRR definition contained above, that can be performed on the quoted equipment. The CPRR shall include all costs for:

· equipment uses

· all consumables, reagents, standards, this shall include material to perform AMR validation for assays with a less than 3 point calibration, calibrators, peer QC comparison software program, printers, middleware/interfacing, parts, and supplies including water system and filters, UPS uninterruptible power supply and barcode printers, probes, etc.

· all necessary maintenance to keep equipment in manufacturer's operating conditions, both preventive maintenance, and emergency repairs

· Training for RMRVAMC personnel operating equipment

· Contractors shall provide delivery, installation and removal of equipment at no additional charge.

If assay is not available on manufacturer’s equipment, third party reagents, controls, calibrators, and consumables shall be included in the contract to accommodate RMRVAMC sites current test menu.

In the event that the consumables are found to be defective and unsuitable for use with the contractor's equipment, or the contractor has failed to comply with the requirements for routine supply delivery, the contractor shall deliver the consumable supplies within a period of twenty-four hours after receipt of the verbal order for priority delivery from the Government activity. If either circumstance has occurred, the contractor shall deliver to the requesting RMRVAMC facility site, in the most expeditious manner possible, without additional cost to the Government. The necessary consumables in sufficient quantity as required to allow operation of the contractor's equipment for one week (under normal Government test load volume). If additional requests for emergency supply delivery are required by the Government, they will be honored by the contractor until the arrival at the Government site of the monthly standing order/routine supplies delivery. Failure to reserve adequate inventory may result in default.

d. Inventory Control Reagents Supplies and Disposable: The contractor shall maintain on Government provided space a continuously stocked inventory of reagents, standards, supplies, disposables and any other material or commonly stocked parts required to properly perform tests on the offered equipment. These items shall be of the highest quality ensuring sensitivity, specificity and tested to assure precision and accuracy. The quality of the products shall be high enough to satisfy proficiency testing standards of the College of American Pathologists (CAP) and the Joint Commission on Accreditation of Health Care Organizations (JCAHO).

e. Maintenance and Repairs:

(4) Provide on-site vendor operator training for all personnel who will run instrument with training provided for all applicable shifts.

4. SPECIFIC INSTRUMENTATION AND EQUIPMENT REQUIREMENTS:

1. Contractor shall provide a minimum of two mirrored chemistry and immunoassay analyzers adequate for the test volumes of RMRVAMC. Additional instrumentation may be provided so long as it fits the available space in that section.

1) Analyzers:

· Small (short) volume and clot detection

· Hemolysis, Icterus, Lipemia (H,I,L) detection

· STAT sampling prioritization, e.g. front loading of samples

2) The automation line:

· Early detection and troubleshooting capability of unacceptable specimens (eg. test and tube type mismatch) so that a new sample may be requested as soon as possible.

· STAT prioritization during the pre-analytic phase on the automation line e.g. capability of STAT samples to bypass routine samples in queue. Tracking of STAT samples from Command Module/Dashboard.

· 2 centrifuges with short total cycle times, i.e. once a set of 5 tubes reaches the centrifuge, the time taken to load and unload following a 5 min centrifugation at 2400 g should be < 9 minutes.

· The two centrifuges shall have the ability to function with different centrifugation profiles when attached to the automation. Comment by Urenda, Tania A.: ? Comment by Urenda, Tania A.: Comment by Urenda, Tania A.:

· Automation shall be compatible with non-preservative tubes for urine chemistry that can go directly on the automation line

· Sample aliquotter must be on the line and use disposable tips

· Automation must be able to recap tubes using screw caps or push caps

· Include a tube decapper, able to uncap rubber push stoppers and hemogard caps, and a recapper

· Include a refrigerated tube storage module

· Storage module must allow retrieval of specimens if the automation line is down through customer-approved secondary access to the refrigerated storage module (i.e. without vendor presence)

· Capacity of holding approximately 14,000 samples at one time

· Auto-disposal of expired specimens

3) Laboratory Test Menu:

· RMRVAMC’s current test menu is attached, the performance ability of the following tests is required:

· Troponin with an assay time < 20 mins.

· Intra-operative PTH assay

· Live NT-Pro-BNP or equivalent

· RMRVAMC will be capable of performing these additional tests:

· HbA1C

· Free Kappa/Free Lambda light chains

· Methotrexate

4) Consumables:

· On-board stability of reagents should be 3 months or longer, for 75% of analytes, longer stability preferred

· Majority of reagents should be liquid and ready to use, without need for manual mixing or room temp equilibration.

· Consumables provided by the vendor shall include reagents and calibrators, but an outside source (i.e. non-awarded vendor) will be sought for controls and will not be included in this contract

5) Lab Information System/IT shall include:

· Back-up data server

· Computer command modules with printers

· Instrument based software that predicts reagent usage based on testing data

· Automated rules based, repeat testing capability

· Automated rules based, reflex testing capability

· Lean process for test result validation and auto-verification that is compatible with the VA’s LIS (currently VistA).

· IT/Workflow consultation and implementation.

· Software should be provided with at least 6 thin client licenses.

6) Instrumentation Footprint:

· Instrumentation footprint shall fit within the available space of the Clinical Chemistry Section

7) Misc. requirements:

· 24/7 phone and in person technical support

· Assistance with assay validation (performance of validation and collation of data in presentable form) to laboratory staff. This will include method correlation, AMR verification, Precision (within run and between run 5 days), HIL studies using readily available materials from Biorad or other vendors, Carryover studies for 3 analytes if disposable tips are not used.

· Assistance with input of assay parameters/technical data in the instrument software.

· Project management support during the install of the new automation line.

5. SPECIAL REQUIREMENTS:

In addition to the general and specific requirements for the Chemistry and Immunochemistry Cost-Per-Reportable Result stated above, the contractor shall make every attempt to provide equipment, peripherals and supplies meeting the following requirements, characteristics and capabilities:

Characteristics:

· Cost of auto-verification programming and validation covered in contract should the VA software change allow for this option during the duration of this contract.

· Detail time to STAT result from time sample is placed on instrument and exactly how the interrupted run is delayed.

· provide the number of instruments operating in the United States and provide information on said equipment, to include record of hardware and software reliability, reagent recall history in past two years, percentage of downtime and average number of service calls per month for each piece of equipment/systems offered.

· Additionally, offeror shall provide details of the location of maintenance personnel in relation to VISN 19 and the amount of territory covered by that personnel and experience of maintenance personnel servicing VISN 19.

Software:

· Look up capabilities for results on samples being processed.

· Ability to store calibration curves for at least two different lot numbers of reagents held on-board.

· Ability to perform automatic on-board dilutions of all sample types for out-of-range results.

· Ability to trigger automatic repeat testing of critical values.

· Ability to add additional tests to already programmed sample.

· Ability to load reagents while instrument is running.

· Ability to detect and alert operator to “short” samples.

· Ability to detect and alert operator to clotted samples.

· Ability to trigger reflex testing.

· Ability to alert user and/or automatically discard empty/expired reagent containers.

· Ability to provide STAT testing and perform calibration curves during routine runs without excess delay in analysis in progress.

· On-board sample inventory.

· Ability to manually repeat testing of specimens currently loaded on instrument.

· Software allows review of QC and patient results for single analyte to help in troubleshooting.

· Software upgrades should be automatic and include training if needed.

· Software is upgradeable (provide list of versions).

· Minimal screen changes when manually programming samples for testing.

· Desirable features of software include programmable rules for reporting, auto-verification, and reflex testing.

· Above software features can be accomplished by instrument software or middleware. If middleware is needed, include necessary hardware and software in contract and CPRR calculation.

· Ability to store and archive results and differentiate which instrument performed them for up to 2 years.

· Ability to differentiate which instrument performed the test if site has multiple instruments.

· Ability to order QC on multiple lots numbers of reagents.

· Ability to recall current and prior on-board reagent and calibration inventory with lot numbers and time in use.

· Software will hold patient result when QC is out of limits, until all QC issues have been resolved.

· Software will require new lots of reagent to be calibrated and QC performed before being able to report patient testing.

· If middleware is needed, the middleware has the ability to create calculations for tests result(s) when necessary.

e. Specimen inventory control software and supplies, to track completed samples in storage, priced in quote for those sites who desire it.

f. Equipment shall be versatile and provide efficient hardware capabilities.

· Analyzer performs both chemistry and immunochemistry testing (workstation consolidation for increased efficiency).

· High test throughput per hour.

· Quick time to first result.

· Analyzer accommodates multiple patient tube sizes.

· Accommodates direct testing from commercial serum/plasma transport tubes.

· Vendor supplies short sample cup that fits inside primary tube to allow original primary barcode reading.

· Large reagent bay to accommodate all reagents for all analytes for on-board menu maximization (walk-away enhancement).

· Uninterruptible power supply (surge protection + battery backup) provided and serviced by vendor for sites requiring such.

· Hardware upgrades are available as needed and include any necessary training.

· Laboratory has space for instrument and peripherals. Vendor will supply plan for placement of new analyzer(s) prior to initial method validation and after when transitioning to new instruments. Plans must be site-specific and accurately reflect available space at each site.

· For track systems, automation of centrifuge loading and unloading, tube de-capping and re-capping of samples, sample filing system and sample storage are available options.

· Track systems must be reliable with a low frequency of downtime. Vendor to provide user statistics.

· All parts and items needed for maintaining and running track system covered in contract.

g. Equipment and software shall at a minimum, provide operator-friendly maintenance requirements.

· Routine maintenance takes minimal tech time.

· Routine maintenance, function checks and calibrations cause little or no delay to testing.

· Reliable technology used for electrolytes.

· Instrument troubleshooting is easy and straightforward.

· Instrument is connected via modem to the vendor hotline, which can view instrument status and remotely control troubleshooting process.

h. Electronic documentation of maintenance records with the ability to alert users when tasks are due.

Reagent and Standards: Convenient Reagent and Standard Use

· Extended calibration life for most analytes – little or to no daily/weekly calibrations.

· Automatic calibration of electrolytes.

· Liquid calibrators for most/all tests.

· Liquid reagents with very little or no reagent preparation for most/all tests.

· Enzyme verifiers available to periodically check performance of enzyme tests that lack standards.

· Reagents have prolonged shelf life and stability once opened/on-board.

· Various reagent sizes for large/small volume facilities.

· On-board reagent inventory.

· Instrument alerts operator to regents/consumables needed to complete testing.

· On-board reagent refrigeration.

· Vendor shall characterize each method and provide exact vendor guaranteed minimum linearity/AMR, CRR limits. Disclosure of methods with less than 3-point calibrators.

· As new methods are released for the instrument, the updates are automatically enabled promptly and at no cost to user.

· Advantage for minimum of 3-point calibration or verifiers for general chem. Reagents (accuracy enhancement, plus using alternate lot of calibrators can stand for bi-annual calibration verification and AMR validation required by CAP without added expense to user.)

· Provide values for calibrators.

QC Data Management: Versatile and convenient QC Data Management.

· Disk storage and/or submission of QC data for peer comparisons.

· Ability to view and print daily and monthly results, and Levy-Jennings graphs for our own data.

· Inter-laboratory peer comparisons forwarded monthly.

· Ability to store QC values for second lot number during crossovers.

· Ability to retain QC data from second lot number when put into use.

Invoicing: Invoicing: Test counts for invoicing by CPRR automated by modem or software.

b. Contractors shall provide a plan for transitioning services from the incumbent contractor to the newly awarded contractor. Contractor shall not exceed 60 days for installation. During this time, the VA primary operators shall be trained at the Contractor’s training site. Failure of the contractor to conform to this transition, installation, and training period shall be considered sufficient cause to terminate contract for cause under the Termination for Cause clause of the contract. The VA shall have sole discretion in the decision to terminate for failure to comply.

c. Instrument and method validations by Contractor shall not exceed 90 days after installation of analyzers, with an extra month for validation of interfaces. During this time, Contractor shall provide fully editable electronic copies of all methods, instruments, operations, and maintenance procedures to be used for the preparation of site specific standard operating procedures (SOPs).

d. Billing by Contractor starts on the first day of patient testing after all installation, training, method and interface validations have been completed and accepted in writing by the Pathologist or Medical Director. At that time, the awarded contractor shall have completed full transition of all services under this agreement and shall have full and sole responsibility for services under the awarded BPA.

8. BUSINESS ASSOCIATE AGREEMENT:

The contractor awarded this contract shall enter into a fully actuated Business Associate Agreement with the VA.

9. RECORDS MANAGEMENT:

The following standard items relate to records generated in executing the contract and should be included:

· Contractor shall treat all deliverables under the contract as the property of the U.S. Government for which the Government Agency shall have unlimited rights to use, dispose of, or disclose such data contained therein as it determines to be in the public interest.

· Contractor shall not create or maintain any records that are not specifically tied to or authorized by the contract using Government IT equipment and/or Government records.

· Contractor shall not retain, use, sell, or disseminate copies of any deliverable that contains information covered by the Privacy Act of 1974 or that which is generally protected by the Freedom of Information Act.

· Contractor shall not create or maintain any records containing any Government Agency records that are not specifically tied to or authorized by the contract.

· The Government Agency owns the rights to all data/records produced as part of this contract.

· The Government Agency owns the rights to all electronic information (electronic data, electronic information systems, electronic databases, etc.) and all supporting documentation created as part of this contract. Contractor must deliver sufficient technical documentation with all data deliverables to permit the agency to use the data.

· Contractor agrees to comply with Federal and Agency records management policies, including those policies associated with the safeguarding of records covered by the Privacy Act of 1974. These policies include the preservation of all records created or received regardless of format [paper, electronic, etc.] or mode of transmission [e-mail, fax, etc.] or state of completion [draft, final, etc.].

1. No disposition of documents will be allowed without the prior written consent of the Contracting Officer. The Agency and its contractors are responsible for preventing the alienation or unauthorized destruction of records, including all forms of mutilation. Willful and unlawful destruction, damage or alienation of Federal records is subject to the fines and penalties imposed by 18 U.S.C. 2701. Records may not be removed from the legal custody of the Agency or destroyed without regard to the provisions of the agency records schedules.

2. Contractor shall be required to obtain the Contracting Officer's approval prior to engaging in any contractual relationship (sub-contractor) in support of this contract requiring the disclosure of information, documentary material and/or records generated under, or relating to, this contract. The Contractor (and any sub-contractor) shall to abide by Government and Agency guidance for protecting sensitive and proprietary information.

B.3 SCHEDULE

Base Year: December 1, 20 through November 30, 2021 Rocky Mountain Regional VA Medical Center

(CPRR)

Unit Cost

Total Cost

Tox Screens

Base Year Estimated Cost: $

Option Year 1: December 1, 2021 through November 30, 2022 Rocky Mountain Regional VA Medical Center

(ASSAYS)

(CPRR)

Unit Cost

Total Cost

Tox Screens

Option Year 1 Estimated Cost:$

Option Year 2: December 1, 2022 through November 30, 2023

(ASSAYS)

(CPRR)

Unit Cost

Total Cost

Tox Screens

Option Year 2 Estimated Cost:$

Option Year 3: December 1, 2023 through November 30, 2024

(ASSAYS)

(CPRR)

Unit Cost

Total Cost

Tox Screens

Option Year 3 Estimated Cost:$

Option Year 4: December 1, 2024 through November 30, 2025

(ASSAYS)

(CPRR)

Unit Cost

Total Cost

Tox Screens

Option Year 4 Estimated Cost:$

Base Year Estimated Cost: _________________ Option Year 1 Estimated Cost:_______________ Option Year 2 Estimated Cost:_______________ Option Year 3 Estimated Cost:_______________ Option Year 4 Estimated Cost:__________________ Estimated Total Contract Cost:___________________